Glenmark launches generic vitamin K1 injectable emulsion
Glenmark is introducing phytonadione injectable emulsion, 10 mg/ml single dose ampules, which is the generic of Hospira’s vitamin K1 injectable emulsion.
Vitamin K1 injectable emulsion had a market value of approximately $19.7 million, for the 12 months ending November 2024, per IQVIA.
[Read more: Glenmark releases generic Travatan Z]
Marc Kikuchi, president and business head, North America at Glenmark, said, “We are excited to announce the launch of phytonadione injectable emulsion, 10 mg/ml single dose ampules, growing our portfolio of products within the institutional channel, while also strengthening our commitment to bring to market quality and affordable alternatives for patients.”
[Read more: Glenmark debuts Olopatadine Hydrochloride Ophthalmic Solution OTC]
